These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 386707)

  • 1. Immunopathology of the glomerular changes in chronic pyelonephritis.
    Yonezawa S
    Acta Pathol Jpn; 1979 Sep; 29(5):677-85. PubMed ID: 386707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathology of the end-stage kidney. Immunoglobulin and complement component deposition in nonimmune disease.
    Velosa J; Miller K; Michael AF
    Am J Pathol; 1976 Jul; 84(1):149-62. PubMed ID: 779494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glomerular immunopathology: comparative study with immunofluorescence and immunoperoxidase (author's transl)].
    Vieira LM; Sarno EN; Ruzany F; De Lacerda PR
    Rev Bras Pesqui Med Biol; 1979 Dec; 12(6):377-81. PubMed ID: 396606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of immunoglobulin depositions of glomerular sialic acids in patients with IgA nephropathy.
    Tomino Y; Sakai H; Miura M; Suga T; Yagame M; Endoh M; Nomoto Y
    Am J Nephrol; 1986; 6(3):187-92. PubMed ID: 3526892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune deposits in human glomerulopathy. Fluorescent microscopy findings in 366 kidney biopsies correlated to symptoms, clinical course and immunosuppressive therapy.
    Larsen S; Brun C
    Acta Pathol Microbiol Scand A; 1979 Sep; 87A(5):321-33. PubMed ID: 393071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical demonstration of serum beta2-glycoprotein III in normal and diseased human glomeruli.
    Chase WH; Prochaska H
    Clin Immunol Immunopathol; 1976 Mar; 5(2):247-57. PubMed ID: 58748
    [No Abstract]   [Full Text] [Related]  

  • 7. Glomerular immune deposits in kidneys from patients with no clinical or light microscopic evidence of glomerulonephritis. Assessment of the influence of autolysis on identification of immunoglobulins and complement.
    Larsen S
    Acta Pathol Microbiol Scand A; 1979 Sep; 87A(5):313-9. PubMed ID: 393070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive evaluation of the significance of immunofluorescent findings on clinicopathological features in IgA nephropathy.
    Katafuchi R; Nagae H; Masutani K; Tsuruya K; Mitsuiki K
    Clin Exp Nephrol; 2019 Feb; 23(2):169-181. PubMed ID: 30066158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunofluorescence staining for the detection of immunoglobulins and complement (C3) in dogs with renal disease.
    Aresu L; Pregel P; Bollo E; Palmerini D; Sereno A; Valenza F
    Vet Rec; 2008 Dec; 163(23):679-82. PubMed ID: 19060316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA glomerular deposits in renal disease.
    Berger J
    Transplant Proc; 1969 Dec; 1(4):939-44. PubMed ID: 4107073
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunohistological aspects of nephropathy with minimal lesions].
    Barbiano di Belgioioso G; Busnach G; Galato R; Torti G; Andreola S; Surian M
    Boll Ist Sieroter Milan; 1977 Jul; 56(3):235-43. PubMed ID: 901637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ACTH-induced renal glomerular lesion in the mouse: immunofluorescence microscopy.
    Feldman DL; Gorfien SF; Christian JJ
    J Pathol; 1983 Mar; 139(3):363-78. PubMed ID: 6300362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpretation of immunofluorescent patterns in renal diseases.
    Valenzuela R; Deodhar SD
    Pathobiol Annu; 1980; 10():183-221. PubMed ID: 7003493
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of IgG, IgM, and C3 in experimental murine IgA nephropathy.
    Emancipator SN; Lamm ME
    Semin Nephrol; 1987 Dec; 7(4):286-8. PubMed ID: 3328245
    [No Abstract]   [Full Text] [Related]  

  • 15. IgA-associated renal diseases: antibodies to environmental antigens in sera and deposition of immunoglobulins and antigens in glomeruli.
    Russell MW; Mestecky J; Julian BA; Galla JH
    J Clin Immunol; 1986 Jan; 6(1):74-86. PubMed ID: 3514654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a working definition of C3 glomerulopathy by immunofluorescence.
    Hou J; Markowitz GS; Bomback AS; Appel GB; Herlitz LC; Barry Stokes M; D'Agati VD
    Kidney Int; 2014 Feb; 85(2):450-6. PubMed ID: 24067430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of mesangial complement in the hematuria of experimental IgA nephropathy.
    Emancipator SN; Ovary Z; Lamm ME
    Lab Invest; 1987 Sep; 57(3):269-76. PubMed ID: 3306149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of immunoglobulin depositions by immunofluorescence and/or immunoperoxidase (P-AP method) in patients with IgA nephropathy.
    Miura M; Tomino Y; Nomoto Y; Sakai H; Osamura Y
    Tokai J Exp Clin Med; 1987 Dec; 12(5-6):343-7. PubMed ID: 3334190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular C3 receptors in human renal disease.
    Pettersson EE; Bhan AK; Schneeberger EE; Collins AB; Colvin RB; McCluskey RT
    Kidney Int; 1978 Mar; 13(3):245-52. PubMed ID: 651124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technical improvements in the immunoperoxidase study of renal biopsy specimens.
    Howie AJ; Gregory J; Thompson RA; Adkins MA; Niblett AJ
    J Clin Pathol; 1990 Mar; 43(3):257-9. PubMed ID: 2185285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.